Dextenza
Payments companies reported to CMS as associated with Dextenza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dextenza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dextenza
These are the largest totals companies reported as associated with Dextenza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joseph Kavanagh | Seguin, TX | Ophthalmology | $40,189.96 |
| Miranda Bishara | Prairie Village, KS | Ophthalmology | $32,902.05 |
| Mahmoud Khaimi | Edmond, OK | Glaucoma Specialist | $30,296.76 |
| Mihir Parikh | La Jolla, CA | Ophthalmology | $26,403.55 |
| Jeffrey Martin | Smithtown, NY | Ophthalmology | $23,848.55 |
| Inder Singh | Racine, WI | Ophthalmology | $23,317.11 |
| Jordan Graff | Phoenix, AZ | Retina Specialist | $14,294.88 |
| Alice Epitropoulos | Columbus, OH | Ophthalmology | $14,229.12 |
| Eric Mann | Dover, NJ | Ophthalmology | $11,619.52 |
| Goldie Benz | Kansas City, MO | Family | $11,556.32 |
Prescribed Dextenza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.